Model or meal? Farm animal populations as models for infectious diseases of humans

Nature Reviews Microbiology

Volumn 8, Issue 2, 2010, Pages 139-148

  Lanzas, Cristina ^a   Ayscue, Patrick ^a   Ivanek, Renata ^b   Gröhn, Yrjö T ^a  

^a Department of Obstetrics Gynecology   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAREK DISEASE VACCINE;

ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; CAPRINE ARTHRITIS ENCEPHALITIS VIRUS; CRYPTOSPORIDIUM PARVUM; DISEASE MODEL; DISEASE TRANSMISSION; ESCHERICHIA COLI; FARM ANIMAL; GENETIC REASSORTMENT; HEPATITIS E VIRUS; HOST PATHOGEN INTERACTION; HUMAN; INFECTION; INFECTION CONTROL; MARDIVIRUS; MATHEMATICAL MODEL; MYCOBACTERIUM BOVIS; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SALMONELLA ENTERICA; VETERINARY MEDICINE; VISNA VIRUS; ZOONOSIS; ANIMAL; BIOLOGICAL MODEL; COMMUNICABLE DISEASE; DOMESTIC ANIMAL; MICROBIOLOGY; POPULATION; VIROLOGY;

ANIMALIA;

ANIMALS; ANIMALS, DOMESTIC; COMMUNICABLE DISEASES; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, BIOLOGICAL; POPULATION;

EID: 75749090456     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro2268     Document Type: Review

References (116)

1. WHO. The World Health Report (Geneva, 2004).
2. Anderson, R. M. & May, R. M. Infectious Diseases of Humans: Dynamics and Control (eds Anderson, R. M. & May, R. M.) (Oxford Univ. Press, Oxford, UK, 1992).
3. Ferguson, N. M. et al. Strategies for mitigating an influenza pandemic. Nature 442, 448-452 (2006).
4. Elbasha, E. H., Dasbach, E. J. & Insinga, R. P. Model for assessing human papillomavirus vaccination strategies. Emerg. Infect. Dis. 13, 28-41 (2007).
5. Blower, S., Schwartz, E. J. & Mills, J. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. AIDS Rev. 5, 113-125 (2003).
6. Cohen, T., Colijn, C. & Murray, M. Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines. Proc. Natl Acad. Sci. USA 105, 16302-16307 (2008).
7. Wearing, H. J., Rohani, P. & Keeling, M. J. Appropriate models for the management of infectious diseases. PLoS Med. 2, 621-627 (2005).
8. Lloyd, A. L. Realistic distributions of infectious periods in epidemic models: changing patterns of persistence and dynamics. Theor. Popul. Biol. 60, 59-71 (2001).
9. Simpson, R. E. Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet 2, 549-554 (1952).
10. Alizon, S., Hurford, A., Mideo, N. & Van Baalen, M. Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future. J. Evol. Biol. 22, 245-259 (2009).
11. Ebert, D. & Bull, J. J. Challenging the trade-off model for the evolution of virulence: is virulence management feasible? Trends Microbiol. 11, 15-20 (2003).
12. Greenwood, M., Bradford-Hill, A., Topley, W. W. C. & Wilson, J. Experimental epidemiology: Medical Research Council special report No.209 (HM Stationary Office, London, UK, 1936).
13. Kermack, W. O. & McKendrick, A. G. Contribution to the mathematical theory of epidemics, IV. Analysis of experimental epidemics of the virus disease mouse ectromelia. J. Hyg. (Lond.) 37, 172-187 (1936).
14. Kermack, W. O. & McKendrick, A. G. Contribution to the mathematical theory of epidemics, V. Analysis of experimental epidemics of mouse typhoid: a bacterial disease conferring incomplete immunity. J. Hyg. (Lond.) 39, 271-288 (1936).
15. Grenfell, B. T. et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303, 327-332 (2004).
16. Ferguson, N. M., Donnelly, C. A., Woolhouse, M. E. J. & Anderson, R. M. The epidemiology of BSE in cattle herds in Great Britain. II. Model construction and analysis of transmission dynamics. Phil. Trans. R. Soc. Lond. B 352, 803-838 (1997).
17. Ferguson, N. M., Donnelly, C. A. & Anderson, R. M. The foot-and-mouth epidemic in Great Britain: pattern of spread and impact of interventions. Science 292, 1155-1160 (2001).
18. Wiles, S., Hanage, W. P., Frankel, G. & Robertson, B. Modelling infectious disease-time to think outside the box? Nature Rev. Microbiol. 4, 307-312 (2006).
19. Woolhouse, M. E. J. & Gowtage-Sequeria, S. Host range and emerging and reemerging pathogens. Emerg. Infect. Dis. 11, 1842-1847 (2005).
20. Cleaveland, S., Laurenson, M. K. & Taylor, L. H. Diseases of humans and their domestic mammals: pathogen characteristics, host range and the risk of emergence. Phil. Trans. R. Soc. Lond. B 356, 991-999 (2001).
21. Larson, E. Community factors in the development of antibiotic resistance. Annu. Rev. Public Health 28, 435-447 (2007).
22. Furuya, E. Y. & Lowy, F. D. Antimicrobial-resistant bacteria in the community setting. Nature Rev. Microbiol. 4, 36-45 (2006).
23. Lanzas, C. et al. The risk and control of Salmonella outbreaks in calf-raising operations: a mathematical modeling approach. Vet. Res. 39, 61 (2008).
24. Bergstrom, C. T. & Feldgarden, M. in Evolution in Health and Disease (eds Stearns, S. C. & Koella, J.) 125-137 (Oxford Univ. Press, Oxford, UK, 2008).
25. Woolhouse, M. E. J. et al. Heterogeneities in the transmission of infectious agents: Implications for the design of control programs. Proc. Natl Acad. Sci. USA 94, 338-342 (1997).
26. Keeling, M. J. & Rohani, P. Estimating spatial coupling in epidemiological systems: a mechanistic approach. Ecol. Lett. 5, 20-29 (2002).
27. Meeusen, E. N. T., Walker, J., Peters, A., Pastoret, P.-P. & Jungersen, G. Current status of veterinary vaccines. Clin. Microbiol. Rev. 20, 489-510 (2007).
28. Lu, Z. et al. The importance of culling in Johne's disease control. J. Theor. Biol. 254, 135-146 (2008).
29. Coleman, P. G., Perry, B. D. & Woolhouse, M. E. J. Endemic stability-a veterinary idea applied to human public health. Lancet 357, 1284-1286 (2001).
30. Nagao, Y. & Koelle, K. Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever. Proc. Natl Acad. Sci. USA 105, 2238-2243 (2008).
31. Egger, J. R. et al. Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control. Bull. World Health Organ. 86, 187-196 (2008).
32. Plowright, R. K., Sokolow, S. H., Gorman, M. E., Daszak, P. & Foley, J. E. Causal inference in disease ecology: investigating ecological drivers of disease emergence. Front. Ecol. Environ. 6, 420-429 (2008).
33. Ivanek, R., Gröhn, Y. T., Jui-Jung Ho, A. & Wiedmann, M. Markov chain approach to analyze the dynamics of pathogen fecal shedding-example of Listeria monocytogenes shedding in a herd of dairy cattle. J. Theor. Biol. 245, 44-58 (2007).
34. Nodelijk, G. et al. A quantitative assessment of the effectiveness of PRRSV vaccination in pigs under experimental conditions. Vaccine 19, 3636-3644 (2001).
35. Velthuis, A. G. J., Bouma, A., Katsma, W. E. A., Nodelijk, G. & De Jong, M. C. M. Design and analysis of small-scale transmission experiments with animals. Epidemiol. Infect. 135, 202-217 (2007).
36. + E. coli for F4-receptor-positive and-negative piglets: one-to-one transmission experiment. Epidemiol. Infect. 132, 1039-1048 (2004).
37. Park, A. W. et al. The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population. Philos. Trans. R. Soc. Lond. B 271, 1547-1555 (2004).
38. Orsel, K., Dekker, A., Bouma, A., Stegeman, J. A. & de Jong, M. C. M. Quantification of foot and mouth disease virus excretion and transmission within groups of lambs with and without vaccination. Vaccine 25, 2673-2679 (2007).
39. Velthuis, A. G. J., de Jong, M. C. M., Stockhofe, N., Vermeulen, T. M. M. & Kamp, E. M. Transmission of Actinobacillus pleuropneumoniae in pigs is characterized by variation in infectivity. Epidemiol. Infect. 129, 203-214 (2002).
40. Andraud, M. et al. Modelling the time-dependent transmission rate for porcine circovirus type 2 (PCV2) in pigs using data from serial transmission experiments. J. R. Soc. Interface 6, 39-50 (2009).
41. Zuckerman, A. J. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 355, 1382-1384 (2000).
42. Gandon, S., Mackinnon, M. J., Nee, S. & Read, A. F. Imperfect vaccines and the evolution of pathogen virulence. Nature 414, 751-756 (2001).
43. Andre, J. B. & Gandon, S. Vaccination, within-host dynamics, and virulence evolution. Evolution 60, 13-23 (2006).
44. Gandon, S. & Day, T. The evolutionary epidemiology of vaccination. J. R. Soc. Interface 4, 803-817 (2007). This paper presents a theoretical model that predicts the short-and long-term epidemiological and evolutionary consequences of vaccination.
45. Read, A. F. & Mackinnon, M. J. in Evolution in Health and Disease (eds Stearns, S. C. & Koella, J.) 139-152 (Oxford Univ. Press, Oxford, UK, 2008).
46. Mackinnon, M. J., Gandon, S. & Read, A. F. Virulence evolution in response to vaccination: the case of malaria. Vaccine 26, C42-C52 (2008).
47. Gimeno, I. M. Marek's disease vaccines: a solution for today but a worry for tomorrow? Vaccine 26, C31-C41 (2008).
48. Osterrieder, N., Kamil, J. P., Schumacher, D., Tischer, B. K. & Trapp, S. Marek's disease virus: from miasma to model. Nature Rev. Microbiol. 4, 283-294 (2006).
49. Loo, V. G. et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353, 2442-2449 (2005).
50. Henderson, D. K. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms. Am. J. Med. 11 9, S45-S52 (2006).
51. Davis, M. A., Hancock, D. D. & Besser, T. E. Multiresistant clones of Salmonella enterica: the importance of dissemination. J. Lab. Clin. Med. 140, 135-141 (2002).
52. Enne, V. I., Livermore, D. M., Stephens, P. & Hall, L. M. C. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357, 1325-1328 (2001).
53. Martinez, J. L. & Baquero, F. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 44, 1771-1777 (2000).
54. Baker-Austin, C., Wright, M. S., Stepanauskas, R. & McArthur, J. V. Co-selection of antibiotic and metal resistance. Trends Microbiol. 14, 176-182 (2006).
55. Beaber, J. W., Hochhut, B. & Waldor, M. K. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427, 72-74 (2004).
56. Khachatryan, A. R., Hancock, D. D., Besser, T. E. & Call, D. R. Role of calf-adapted Escherichia coli in maintenance of antimicrobial drug resistance in dairy calves. Appl. Environ. Microbiol. 70, 752-757 (2004).
57. Khachatryan, A. R., Hancock, D. D., Besser, T. E. & Call, D. R. Antimicrobial drug resistance genes do not convey a secondary fitness advantage to calf-adapted Escherichia coli. Appl. Environ. Microbiol. 72, 443-448 (2006).
58. Khachatryan, A. R., Besser, T. E., Hancock, D. D. & Call, D. R. Use of a nonmedicated dietary supplement correlates with increased prevalence of streptomycin-sulfa-tetracycline-resistant Escherichia coli on a dairy farm. Appl. Environ. Microbiol. 72, 4583-4588 (2006).
59. Khachatryan, A. R., Besser, T. E. & Call, D. R. The streptomycin-sulfadiazine-tetracycline antimicrobial resistance element of calf-adapted Escherichia coli is widely distributed among isolates from Washington State cattle. Appl. Environ. Microbiol. 74, 391-395 (2008).
60. Ray, K. A. et al. Antimicrobial susceptibility of Salmonella from organic and conventional dairy farms. J. Dairy Sci. 89, 2038-2050 (2006).
61. Thakur, S., Tadesse, D. A., Morrow, M. & Gebreyes, W. A. Occurrence of multidrug resistant Salmonella in antimicrobial-free (ABF) swine production systems. Vet. Microbiol. 125, 362-367 (2007).
62. Sato, K., Bartlett, P. C. & Saeed, M. A. Antimicrobial susceptibility of Escherichia coli isolates from dairy farms using organic versus conventional production methods. J. Am. Vet. Med. Assoc. 226, 589-594 (2005).
63. Walk, S. T. et al. Influence of antibiotic selection on genetic composition of Escherichia coli populations from conventional and organic dairy farms. Appl. Environ. Microbiol. 73, 5982-5989 (2007).
64. Begon, M. et al. A clarification of transmission terms in host-microparasite models: numbers, densities and areas. Epidemiol. Infect. 129, 147-153 (2002).
65. McCallum, H., Barlow, N. & Hone, J. How should pathogen transmission be modelled? Trends Ecol. Evol. 16, 295-300 (2001).
66. Bjornstad, O. N., Finkenstadt, B. F. & Grenfell, B. T. Dynamics of measles epidemics: estimating scaling of transmission rates using a Time series SIR model. Ecol. Monogr. 72, 169-184 (2002).
67. Bouma, A., Dejong, M. C. M. & Kimman, T. G. Transmission of pseudorabies virus within pig populations is independent of the size of the population. Prev. Vet. Med. 23, 163-172 (1995).
68. Bouwknegt, M. et al. Estimation of hepatitis E virus transmission among pigs due to contact-exposure. Vet. Res. 39, 40 (2008).
69. Alexandersen, S., Quan, M., Murphy, C., Knight, J. & Zhang, Z. Studies of quantitative parameters of virus excretion and transmission in pigs and cattle experimentally infected with foot-and-mouth disease virus. J. Comp. Pathol. 129, 268-282 (2003).
70. Woolhouse, M. E. J. et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc. Natl Acad. Sci. USA 94, 338-342 (1997).
71. Lloyd-Smith, J. O., Schreiber, S. J., Kopp, P. E. & Getz, W. M. Superspreading and the effect of individual variation on disease emergence. Nature 438, 355-359 (2005).
72. Grenfell, B. T., Wilson, K., Isham, V. S., Boyd, H. E. G. & Dietz, K. Modelling patterns of parasite aggregation in natural populations: trichostrongylid nematode-ruminant interactions as a case study. Parasitology 111, S135-S151 (1995).
73. Quinnell, R. J. Genetics of susceptibility to human helminth infection. Int. J. Parasitol. 33, 1219-1231 (2003).
74. Stear, M. J., Strain, S. & Bishop, S. C. Mechanisms underlying resistance to nematode infection. Int. J. Parasitol. 29, 51-56 (1999).
75. Stear, M. J. et al. The dynamic influence of genetic variation on the susceptibility of sheep to gastrointestinal nematode infection. J. R. Soc. Interface 4, 767-776 (2007).
76. Stear, M. J., Park, M. & Bishop, S. C. The key components of resistance to Ostertagia circumcincta in lambs. Parasitol. Today 12, 438-441 (1996).
77. Bishop, S. C. & Stear, M. J. Modeling of host genetics and resistance to infectious diseases: understanding and controlling nematode infections. Vet. Parasitol. 115, 147-166 (2003).
78. Wolfe, N. D. et al. Naturally acquired simian retrovirus infections in central African hunters. Lancet 363, 932-937 (2004).
79. Antia, R., Regoes, R. R., Koella, J. C. & Bergstrom, C. T. The role of evolution in the emergence of infectious diseases. Nature 426, 658-661 (2003).
80. Taubenberger, J. K. et al. Characterization of the 1918 influenza virus polymerase genes. Nature 437, 889-893 (2005).
81. Vincent, A. L., Ma, W., Lager, K. M., Janke, B. H. & Richt, J. A. in Advances in Virus Research (eds Maramorosch, K., Shatkin, A. J. & Murphy, F. A.) 127-154 (Academic, Burlington, 2008).
82. Ma, W. et al. The role of swine in the generation of novel influenza viruses. Zoonoses Public Health 56, 326-337 (2009).
83. Webby, R. J. et al. Evolution of swine H3N2 influenza viruses in the United States. J. Virol. 74, 8243-8251 (2000).
84. Neumann, G., Noda, T. & Kawaoka, Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459, 931-939 (2009).
85. Kuntz-Simon, G. & Madec, F. Genetic and antigenic evolution of swine influenza viruses in Europe and evaluation of their zoonotic potential. Zoonoses Public Health 56, 310-325 (2009).
86. Myers, K. P., Olsen, C. W. & Gray, G. C. Cases of swine influenza in humans: a review of the literature. Clin. Infect. Dis. 44, 1084-1088 (2007).
87. Lessler, J., Cummings, D. A. T., Fishman, S., Vora, A. & Burke, D. S. Transmissibility of swine flu at Fort Dix, 1976. J. R. Soc. Interface 4, 755-762 (2007).
88. Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360, 2605-2615 (2009).
89. Dunham, E. J. et al. Different evolutionary trajectories of European avian-like and classical swine H1N1 influenza A viruses. J. Virol. 83, 5485-5494 (2009).
90. Stech, J., Xiong, X., Scholtissek, C. & Webster, R. G. Independence of evolutionary and mutational rates after transmission of avian influenza viruses to swine. J. Virol. 73, 1878-1884 (1999).
91. Ma, W. et al. Identification of H2N3 influenza A viruses from swine in the United States. Proc. Natl Acad. Sci. USA 104, 20949-20954 (2007).
92. Crawford, P. C. et al. Transmission of equine influenza virus to dogs. Science 310, 482-485 (2005).
93. Webster, R. G. Wet markets-a continuing source of severe acute respiratory syndrome and influenza? Lancet 363, 234-236 (2004).
94. Liu, M. et al. The influenza virus gene pool in a poultry market in South Central China. Virology 305, 267-275 (2003).
95. Klauder, J. V. Interrelations of human and veterinary medicine; discussion of some aspects of comparative dermatology. N. Engl. J. Med. 258, 170-177 (1958).
96. Velthuis, A. et al. Quantification of transmission in one-to-one experiments. Epidemiol. Infect. 128, 193-204 (2002).
97. De Jong, M. C. M. & Kimman, T. G. Experimental quantification of vaccine-induced reduction in virus transmission. Vaccine 12, 761-766 (1994).
98. Borzacchiello, G. & Roperto, F. Bovine papillomaviruses, papillomas and cancer in cattle. Vet. Res. 39, 45 (2008).
99. Meyer, G., Deplanche, M. & Schelcher, F. Human and bovine respiratory syncytial virus vaccine research and development. Comp. Immunol. Microbiol. Infect. Dis. 31, 191-225 (2008).
100. Stump, D. S. & VandeWoude, S. Animal models for HIV AIDS: a comparative review. Comp. Med. 57, 33-43 (2007).
101. Enemark, H. L. et al. Pathogenicity of Cryptosporidium parvum-evaluation of an animal infection model. Vet. Parasitol. 11 3, 35-57 (2003).
102. Feagins, A. R., Opriessnig, T., Huang, Y. W., Halbur, P. G. & Meng, X. J. Cross-species infection of specific-pathogen-free pigs by a genotype 4 strain of human hepatitis E virus. J. Med. Virol. 80, 1379-1386 (2008).
103. Van Rhijn, I., Godfroid, J., Michel, A. & Rutten, V. Bovine tuberculosis as a model for human tuberculosis: advantages over small animal models. Microb. Infect. 10, 711-715 (2008).
104. Bolin, C. A. et al. Infection of swine with Mycobacterium bovis as a model of human tuberculosis. J. Infect. Dis. 176, 1559-1566 (1997).
105. Santos, R. L. et al. Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect. 3, 1335-1344 (2001).
106. Berg, T. P. Acute infectious bursal disease in poultry: a review. Avian Pathol. 29, 175-194 (2000).
107. Escorcia, M. et al. Avian influenza: genetic evolution under vaccination pressure. Virol. J. 5, 15 (2008).
108. Taboga, O. et al. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71, 2606-2614 (1997).
109. Mastroeni, P., Chabalgoity, J. A., Dunstan, S. J., Maskell, D. J. & Dougan, G. Salmonella: immune responses and vaccines. Vet. J. 161, 132-164 (2001).
110. Alexander, K., Warnick, L. & Wiedmann, M. Antimicrobial resistant Salmonella in dairy cattle in the United States. Vet. Res. Commun. 33, 191-209 (2009).
111. Liu, W.-c. et al. Metapopulation dynamics of Escherichia coli O157 in cattle: an exploratory model. J. R. Soc. Interface 4, 917-924 (2007).
112. Glass, E. J. Genetic variation and responses to vaccines. Anim. Health Res. Rev. 5, 197-208 (2007).
113. Courtin, D. et al. Host genetics in African trypanosomiasis. Infect. Genet. Evol. 8, 229-238 (2008).
114. Yates, W. D. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. 46, 225-263 (1982).
115. Magar, R., Larochelle, R., Thibault, S. & Lamontagne, L. Experimental transmission of porcine circovirus type 2 (PCV2) in weaned pigs: a sequential study. J. Comp. Pathol. 123, 258-269 (2000).
116. Zadoks, R. N., Allore, H. G., Hagenaars, T. J., Barkema, H. W. & Schukken, Y. H. A mathematical model of Staphylococcus aureus control in dairy herds. Epidemiol. Infect. 129, 397-416 (2002).